AU2002353803A1 - Direct resolution of racemic threo-methylphenidate hydrochloride - Google Patents

Direct resolution of racemic threo-methylphenidate hydrochloride

Info

Publication number
AU2002353803A1
AU2002353803A1 AU2002353803A AU2002353803A AU2002353803A1 AU 2002353803 A1 AU2002353803 A1 AU 2002353803A1 AU 2002353803 A AU2002353803 A AU 2002353803A AU 2002353803 A AU2002353803 A AU 2002353803A AU 2002353803 A1 AU2002353803 A1 AU 2002353803A1
Authority
AU
Australia
Prior art keywords
methylphenidate hydrochloride
direct resolution
racemic threo
threo
racemic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002353803A
Inventor
Shoucheng Du
Mel H. Epstein
Jeroen Verheijen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sention Inc
Original Assignee
Sention Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sention Inc filed Critical Sention Inc
Publication of AU2002353803A1 publication Critical patent/AU2002353803A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002353803A 2001-10-12 2002-10-11 Direct resolution of racemic threo-methylphenidate hydrochloride Abandoned AU2002353803A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32872201P 2001-10-12 2001-10-12
US60/328,722 2001-10-12
PCT/US2002/032658 WO2003031411A2 (en) 2001-10-12 2002-10-11 Direct resolution of racemic threo-methylphenidate hydrochloride

Publications (1)

Publication Number Publication Date
AU2002353803A1 true AU2002353803A1 (en) 2003-04-22

Family

ID=23282136

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002353803A Abandoned AU2002353803A1 (en) 2001-10-12 2002-10-11 Direct resolution of racemic threo-methylphenidate hydrochloride

Country Status (2)

Country Link
AU (1) AU2002353803A1 (en)
WO (1) WO2003031411A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7897777B2 (en) 2007-01-05 2011-03-01 Archimica, Inc. Process of enantiomeric resolution of D,L-(±)-threo-methylphenidate
HUE043631T2 (en) * 2013-11-08 2019-08-28 Noramco Inc Process for the preparation of methylphenidate and pharmaceutical salts thereof
CN110878021A (en) * 2019-12-05 2020-03-13 济南大学 Preparation method and application of tartaric acid derivative

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9805870A (en) * 1996-01-22 1999-01-31
US6100401A (en) * 1998-04-20 2000-08-08 Novartris Ag Process for preparing the d-threo isomer of methylphenidate hydrochloride

Also Published As

Publication number Publication date
WO2003031411A2 (en) 2003-04-17
WO2003031411A3 (en) 2003-07-24

Similar Documents

Publication Publication Date Title
HK1208446A1 (en) Derivatives of uk-2a uk-2a
AU2001241128A1 (en) Novel amide compounds
AU2002337749A1 (en) Pioglitazone hydrochloride
AU2001218494A1 (en) Resolution of the enantiomers of amlodipine
AU2002309475A1 (en) Esmolol formulation
AU2002305162A1 (en) Polymorphs of fexofenadine hydrochloride
AUPR409401A0 (en) Analgesic compound
AU2003216848A1 (en) Deracemisation of amines
AU2002353803A1 (en) Direct resolution of racemic threo-methylphenidate hydrochloride
HUP0303895A3 (en) Degradation of epothilones
AU2002357701A1 (en) Polymorphs of fexofenadine base
AU2002305868A1 (en) Inhibitors of reggamma
AU2002342940A1 (en) New pharmaceutical compounds
EP1238585B8 (en) Use of esterquats
AU2002246290A1 (en) Superstability of thin-walled structures
AU2002237189A1 (en) New use of phencynonate hydrochloride
AU2002238356A1 (en) New use of phencynonate hydrochloride
AU2002340498A1 (en) Delta 1-pyrroline
AU2002361450A1 (en) Novel pharmaceutical
AU2001246483A1 (en) Allomorph isomer z hydrochloride of ranitidine
AU2002246388A1 (en) Amide compounds
AUPR472201A0 (en) Amide compounds
AUPR916401A0 (en) Amide compounds
AU2002232061A1 (en) Compositions having improved bioavailability of eletriptan
AU2002338026A1 (en) Diphenylbutane amide derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase